IDNA was created on 2019-06-11 by iShares. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 159.08m in AUM and 51 holdings. IDNA tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering.